WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

N NERVOUS SYSTEM
N01 ANESTHETICS

No DDDs have been established in this group because the doses used vary substantially.


N01A ANESTHETICS, GENERAL

This group comprises agents which produce general anesthesia, surgical analgesia or neuroleptanalgesia. See also M03A - Peripherally acting muscle relaxants.
Benzodiazepine derivatives are classified in N05BA or N05CD.


N01AA Ethers
N01AB Halogenated hydrocarbons
N01AF Barbiturates, plain

This group comprises barbiturates used as anesthetics.
Barbiturates used as hypnotics/sedatives and as premedication, see N05CA - Barbiturates, plain.

N01AG Barbiturates in combination with other drugs

Only preparations used as anesthetics are classified in this group. See also N05CB - Barbiturates, combinations.

N01AH Opioid anesthetics

Opioid anesthetics in combination with other anesthetics are classified in this group at separate 5th levels using the corresponding 50-series.
Transdermal, nasal and sublingual formulations of fentanyl are classified in N02AB.
Fentanyl in combination with bupivacaine for e.g. postoperative pain is classified in N01AH51 - fentanyl, combinations.

N01AX Other general anesthetics

This group comprises various plain and combined drugs used to produce anesthesia/analgesia, which cannot be classified in the preceeding groups.
Esketamine for nasal administration is classified in N06AX.

Last updated: 2024-01-26